JP2024524215A - Nlrp3阻害剤を調製するための方法 - Google Patents

Nlrp3阻害剤を調製するための方法 Download PDF

Info

Publication number
JP2024524215A
JP2024524215A JP2023578919A JP2023578919A JP2024524215A JP 2024524215 A JP2024524215 A JP 2024524215A JP 2023578919 A JP2023578919 A JP 2023578919A JP 2023578919 A JP2023578919 A JP 2023578919A JP 2024524215 A JP2024524215 A JP 2024524215A
Authority
JP
Japan
Prior art keywords
group
typically
solvent
piperidine
protected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524215A5 (cg-RX-API-DMAC7.html
Inventor
バーラタ,マレシュ
サンカルブル,ジョゼフィーヌ・エリエット・フランソワーズ
フレイザー,ポール
モンディエール,レジス・ジャン・ジョルジュ
パルグナ,ジェッタ
トサッティ,パオロ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2024524215A publication Critical patent/JP2024524215A/ja
Publication of JP2024524215A5 publication Critical patent/JP2024524215A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98—Nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023578919A 2021-06-23 2022-06-23 Nlrp3阻害剤を調製するための方法 Pending JP2024524215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202141028180 2021-06-23
IN202141028180 2021-06-23
PCT/EP2022/067126 WO2022268935A2 (en) 2021-06-23 2022-06-23 Novel process

Publications (2)

Publication Number Publication Date
JP2024524215A true JP2024524215A (ja) 2024-07-05
JP2024524215A5 JP2024524215A5 (cg-RX-API-DMAC7.html) 2025-06-27

Family

ID=82458485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578919A Pending JP2024524215A (ja) 2021-06-23 2022-06-23 Nlrp3阻害剤を調製するための方法

Country Status (12)

Country Link
US (1) US20240150291A1 (cg-RX-API-DMAC7.html)
EP (1) EP4359385A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024524215A (cg-RX-API-DMAC7.html)
KR (1) KR20240024842A (cg-RX-API-DMAC7.html)
CN (1) CN118019727A (cg-RX-API-DMAC7.html)
AR (1) AR126215A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022300325A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219597A1 (cg-RX-API-DMAC7.html)
IL (1) IL308071A (cg-RX-API-DMAC7.html)
MX (1) MX2023014547A (cg-RX-API-DMAC7.html)
TW (1) TW202317514A (cg-RX-API-DMAC7.html)
WO (1) WO2022268935A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240148839A (ko) * 2022-02-15 2024-10-11 에프. 호프만-라 로슈 아게 1,2,3,5,6,7-헥사히드로-s-인다센 유도체 제조를 위한 공정
EP4638422A1 (en) * 2022-12-23 2025-10-29 F. Hoffmann-La Roche AG Proccesses for the preparation of an nlrp3 inhibitor
WO2025036914A1 (en) 2023-08-16 2025-02-20 F. Hoffmann-La Roche Ag Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide
TW202545527A (zh) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH059102A (ja) * 1990-09-26 1993-01-19 Takeda Chem Ind Ltd 除草剤
JPH0586055A (ja) * 1991-01-24 1993-04-06 Ishihara Sangyo Kaisha Ltd 置換ピリジンスルホンアミド系化合物、それらの製造方法及びそれらを含有する除草剤
WO2010097087A1 (en) * 2009-02-25 2010-09-02 H. Lundbeck A/S Catecholamine derivatives and prodrugs thereof
WO2019008025A1 (en) * 2017-07-07 2019-01-10 Inflazome Limited NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
WO2019211463A1 (en) * 2018-05-04 2019-11-07 Inflazome Limited Novel compounds
CN111393415A (zh) * 2020-04-30 2020-07-10 苏州信诺维医药科技有限公司 一种杂芳腈类化合物及其应用
WO2020157069A1 (en) * 2019-01-28 2020-08-06 NodThera Limited Amino heterocyclic compounds and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0981526B1 (en) * 1997-05-02 2004-02-25 Dr. Reddy's Laboratories Ltd. Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
DK1340757T3 (da) * 2000-11-16 2007-02-12 Sankyo Co 1-methylcarbapenemderivater
EP1403255A4 (en) * 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
CN100360130C (zh) * 2002-04-18 2008-01-09 先灵公司 用作组胺h3拮抗剂的1-(4-哌啶基)苯并咪唑酮
EP1677783A2 (en) * 2003-10-08 2006-07-12 Nicholas Piramal India Limited Fibrinogen receptor antagonists and their use
DOP2006000009A (es) * 2005-01-13 2006-08-15 Arena Pharm Inc Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
ZA200904857B (en) * 2007-02-22 2010-09-29 Merck Serono Sa Quinoxaline compounds and use thereof
JP5898962B2 (ja) * 2012-01-11 2016-04-06 東京応化工業株式会社 レジスト組成物及びレジストパターン形成方法
WO2017095758A1 (en) * 2015-12-01 2017-06-08 Merck Sharp & Dohme Corp. Homobispiperidinyl derivatives as liver x receptor beta agonists, compositions, and their use
GB201712282D0 (en) * 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome
TW201910314A (zh) * 2017-08-15 2019-03-16 愛爾蘭商英弗雷佐姆有限公司 新穎化合物
CN111902141A (zh) * 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
CR20210148A (es) * 2018-09-21 2021-05-18 Novartis Ag Compuestos de isoxazol carboxamida y usos de los mismos
GB201817038D0 (en) 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
GB201819083D0 (en) * 2018-11-23 2019-01-09 Inflazome Ltd Novel compounds

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH059102A (ja) * 1990-09-26 1993-01-19 Takeda Chem Ind Ltd 除草剤
JPH0586055A (ja) * 1991-01-24 1993-04-06 Ishihara Sangyo Kaisha Ltd 置換ピリジンスルホンアミド系化合物、それらの製造方法及びそれらを含有する除草剤
WO2010097087A1 (en) * 2009-02-25 2010-09-02 H. Lundbeck A/S Catecholamine derivatives and prodrugs thereof
WO2019008025A1 (en) * 2017-07-07 2019-01-10 Inflazome Limited NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
WO2019211463A1 (en) * 2018-05-04 2019-11-07 Inflazome Limited Novel compounds
WO2020157069A1 (en) * 2019-01-28 2020-08-06 NodThera Limited Amino heterocyclic compounds and uses thereof
CN111393415A (zh) * 2020-04-30 2020-07-10 苏州信诺维医药科技有限公司 一种杂芳腈类化合物及其应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GIRISH V. AMBULGEKAR ET AL.: "A Novel and Facile Process for the Synthesis of Gliclazide", LETTERS IN ORGANIC CHEMISTRY, vol. 15, JPN6026015970, 2018, pages 760 - 765, ISSN: 0005844555 *
TAKASHI IKAWA ET AL.: "Selective N-alkylation of amines using nitriles under hydrogenation conditions: facile synthesis of", ORG. BIOMOL. CHEM, vol. 10, JPN6026015969, 2012, pages 293 - 304, ISSN: 0005844556 *

Also Published As

Publication number Publication date
EP4359385A2 (en) 2024-05-01
US20240150291A1 (en) 2024-05-09
IL308071A (en) 2023-12-01
WO2022268935A2 (en) 2022-12-29
CN118019727A (zh) 2024-05-10
KR20240024842A (ko) 2024-02-26
MX2023014547A (es) 2024-04-29
AU2022300325A8 (en) 2023-11-16
AU2022300325A1 (en) 2023-11-02
CA3219597A1 (en) 2022-12-29
TW202317514A (zh) 2023-05-01
WO2022268935A3 (en) 2023-02-02
AR126215A1 (es) 2023-09-27

Similar Documents

Publication Publication Date Title
EP4359385A2 (en) Process for the preparation of nlrp3 inhibitors
ES2603028T3 (es) Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
CN110139868B (zh) 制备3-取代的5-氨基-6H-噻唑并[4,5-d]嘧啶-2,7-二酮化合物的方法
US20240400516A1 (en) Processes for the preparation of 1,2,3,5,6,7-hexahydro-s-indacene derivataives
JP2026502847A (ja) Nlrp3阻害剤の調製のためのプロセス
HK40105889A (en) Process for the preparation of nlrp3 inhibitors
ES2912409T3 (es) Intermedios y procesos para la preparación de linagliptina y sus sales
JP2016172755A (ja) 抗ウイルス化合物およびその有用な中間体の調製方法
HK40112968A (en) Processes for the preparation of 1,2,3,5,6,7-hexahydro-s-indacene derivatives
WO2025240465A1 (en) Processes for preparing macrocyclic compounds
IL325043A (en) Process for the preparation of 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indecen-4-yl)carbamoyl)piperidine-4-sulfonamide
HK40012866B (en) Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
HK40012866A (en) Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
BR112019013884B1 (pt) Processo para a preparação de compostos de 5 -amino -6h´ -tiazolo [4,5 -d] pirimidina -2,7 -diona 3 -substituídos

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250618

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260421

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260716